跳至主要内容
临床试验/JPRN-UMIN000002029
JPRN-UMIN000002029已完成2 期

A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2) - A phase II trial of definitive chemoradiotherapy (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)

Kitasato University School of Medicine0 个研究点目标入组 35 人开始时间: 2009年6月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. History of serious drug hypersensitivity 2. Active gastrointestinal bleeding 3. Active infection 4. Severe complication (interstitial pneumonia or pulmonary fibrosis, poorly controlled diabetes mellitus, heart failure, renal failure, liver cirrhosis or etc) 5. Active synchronous or metachronous malignancy other than carcinoma in situ. 6. Mental disorders being treated with antipsychotic agents or requiring treatment 7. Pregnant or lactation women, or women with the possibility of the pregnancy 8. Men who want let to pregnancy 9. Patients who are judged inappropriate for the entry into the study by the investigater

研究者

发起方
Kitasato University School of Medicine

相似试验